TIAA CREF INVESTMENT MANAGEMENT LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,346,000
+77.1%
395,644
+95.6%
0.00%
-100.0%
Q2 2018$760,000
-9.2%
202,238
-1.2%
0.00%0.0%
Q1 2018$837,000
-12.1%
204,7430.0%0.00%0.0%
Q4 2017$952,000
-42.3%
204,743
-11.9%
0.00%0.0%
Q3 2017$1,650,000
+3.6%
232,324
+5.4%
0.00%0.0%
Q2 2017$1,593,000
+21.5%
220,336
+3.6%
0.00%0.0%
Q1 2017$1,311,000
-1.6%
212,760
-6.4%
0.00%0.0%
Q4 2016$1,332,000
+5.3%
227,286
-4.6%
0.00%0.0%
Q3 2016$1,265,000
-38.7%
238,148
-23.5%
0.00%
-50.0%
Q2 2016$2,062,000
+36.2%
311,450
-3.9%
0.00%
+100.0%
Q1 2016$1,514,000
-10.9%
324,095
-3.7%
0.00%0.0%
Q4 2015$1,700,000
+38.8%
336,714
-3.3%
0.00%0.0%
Q3 2015$1,225,000
-66.2%
348,098
-4.1%
0.00%
-66.7%
Q2 2015$3,622,000
-16.6%
362,961
+6.4%
0.00%0.0%
Q1 2015$4,343,000
-3.9%
341,151
+6.9%
0.00%0.0%
Q4 2014$4,518,000
-3.3%
319,265
-6.1%
0.00%0.0%
Q3 2014$4,674,000
-12.9%
339,914
-2.5%
0.00%
-25.0%
Q2 2014$5,364,000
-7.4%
348,796
+2.6%
0.00%0.0%
Q1 2014$5,795,000
+36.9%
340,090
+4.1%
0.00%
+33.3%
Q4 2013$4,233,000
+27.7%
326,845
-0.4%
0.00%0.0%
Q3 2013$3,314,000
+29.4%
328,110
-4.3%
0.00%
+50.0%
Q2 2013$2,561,000342,8230.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders